HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spontaneous regression of metastatic papillary renal cell cancer after cessation of treatment with sorafenib.

AuthorsTal Grenader, Eli Rosenbaum, Sofia Zilber, Naama Bogot, Linda Shavit
JournalClinical genitourinary cancer (Clin Genitourin Cancer) Vol. 11 Issue 2 Pg. 201-3 (Jun 2013) ISSN: 1938-0682 [Electronic] United States
PMID23266054 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Niacinamide
  • Sorafenib
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Renal Cell (drug therapy)
  • Humans
  • Kidney Neoplasms (drug therapy)
  • Male
  • Neoplasm Metastasis (drug therapy)
  • Niacinamide (analogs & derivatives, therapeutic use)
  • Phenylurea Compounds (therapeutic use)
  • Protein Kinase Inhibitors (therapeutic use)
  • Remission, Spontaneous
  • Sorafenib

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: